Impact of haemoglobin variants on the use of haemoglobin A1c for the diagnosis and monitoring of diabetes: a contextualised review.
Issue Date
2022-04-01Keywords
DIABETESDIAGNOSIS
Haemoglobinopathy
HbA1c
Metadata
Show full item recordJournal
Irish journal of medical scienceDOI
10.1007/s11845-022-02967-2PubMed ID
35362846Item Type
ArticleOther
Language
enEISSN
1863-4362ae974a485f413a2113503eed53cd6c53
10.1007/s11845-022-02967-2
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS).
- Authors: Manley S
- Issue date: 2003 Sep
- Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
- Authors: Simpson TC, Weldon JC, Worthington HV, Needleman I, Wild SH, Moles DR, Stevenson B, Furness S, Iheozor-Ejiofor Z
- Issue date: 2015 Nov 6
- Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.
- Authors: Li J, Gordon SC, Rupp LB, Zhang T, Trudeau S, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Boscarino JA, Schmidt MA, Daida YG, Lu M, CHeCS Investigators
- Issue date: 2019 Jun
- Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
- Authors: Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D
- Issue date: 2008 Jun
- The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
- Authors: Larsen ML
- Issue date: 1997 Jun